Goldschmidt, N., & Rund, D. (2017). Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib. Leukemia & lymphoma, 58(2), 498-500. https://doi.org/10.1080/10428194.2016.1182163
Chicago Style (17th ed.) CitationGoldschmidt, Neta, and Deborah Rund. "Refractory Pure Red Cell Aplasia Associated with Chronic Lymphocytic Leukemia Successfully Treated with Ibrutinib." Leukemia & Lymphoma 58, no. 2 (2017): 498-500. https://doi.org/10.1080/10428194.2016.1182163.
MLA (9th ed.) CitationGoldschmidt, Neta, and Deborah Rund. "Refractory Pure Red Cell Aplasia Associated with Chronic Lymphocytic Leukemia Successfully Treated with Ibrutinib." Leukemia & Lymphoma, vol. 58, no. 2, 2017, pp. 498-500, https://doi.org/10.1080/10428194.2016.1182163.